Literature DB >> 19727726

Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab.

Marco Tuccori, Daniele Focosi, Fabrizio Maggi, Mirco Cosottini, Barbara Meini, Fabio Lena, Corrado Blandizzi, Mario Del Tacca, Mario Petrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19727726     DOI： 10.1007/s00277-009-0819-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

1.  Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy.

Authors:  Marco Tuccori; Daniele Focosi; Corrado Blandizzi; Matteo Pelosini; Sabrina Montagnani; Fabrizio Maggi; Mauro Pistello; Luca Antonioli; Matteo Fornai; Pasquale Pepe; Giuseppe Rossi; Mario Petrini
Journal:  Oncologist       Date:  2010-11-01

2.  Progressive multifocal leukoencephalopathy in transplant recipients.

Authors:  Farrah J Mateen; RajaNandini Muralidharan; Marco Carone; Diederik van de Beek; Daniel M Harrison; Allen J Aksamit; Mary S Gould; David B Clifford; Avindra Nath
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

3.  Progressive multifocal leukoencephalopathy during treatment with rituximab and CHOP chemotherapy in a patient with a diffuse large B-cell lymphoma.

Authors:  Tineke Sikkema; Wouter Jan Schuiling; Mels Hoogendoorn
Journal:  BMJ Case Rep       Date:  2013-01-25

Review 4.  Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?

Authors:  Jennifer Worch; Olga Makarova; Birgit Burkhardt
Journal:  Cancers (Basel)       Date:  2015-01-29       Impact factor: 6.639

5.  Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.

Authors:  Roderick P P W M Maas; Annemarie H G Muller-Hansma; Rianne A J Esselink; Jean-Luc Murk; Clemens Warnke; Joep Killestein; Mike P Wattjes
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 6.  What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?

Authors:  Katherine A Buzzard; Simon A Broadley; Helmut Butzkueven
Journal:  Int J Mol Sci       Date:  2012-10-04       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.